We are live on
!
Find out more
GeneDx Holdings
82 hedge funds and large institutions have $172M invested in GeneDx Holdings in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 13 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
3,623% more call options, than puts
Call options by funds: $1.15M | Put options by funds: $31K
360% more capital invested
Capital invested by funds: $37.3M → $172M (+$134M)
200% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 13
0.68% more ownership
Funds ownership: 1.11% → 1.79% (+0.68%)
5% less funds holding
Funds holding: 86 → 82 (-4)
10% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 20
Holders
82
Holders Change
-4
Holders Change %
-4.65%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
39
Reduced
13
Closed
20
Calls
$1.15M
Puts
$31K
Net Calls
+$1.12M
Net Calls Change
+$74K
Top Buyers
| 1 |
CC
Casdin Capital
New York
|
+$34.6M |
| 2 |
CM
Corvex Management
New York
|
+$31.4M |
| 3 |
DM
Deerfield Management
New York
|
+$19M |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$9.23M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$7.61M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$2.68M |
| 2 |
Renaissance Technologies
New York
|
-$820K |
| 3 |
ZDA
Zweig-DiMenna Associates
New York
|
-$375K |
| 4 |
D.E. Shaw & Co
New York
|
-$172K |
| 5 |
HF
HRT Financial
New York
|
-$150K |